NovoCure Limited (NVCR)
(Delayed Data from NSDQ)
$11.13 USD
-0.38 (-3.30%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $11.14 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth A Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, NovoCure Limited has a market cap of $1.29B, which represents its share price of $11.51 multiplied by its outstanding shares number of 111.80M. As a small-cap company, NVCR's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
NVCR 11.13 -0.38(-3.30%)
Will NVCR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NVCR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NVCR
NovoCure (NVCR) Reports Q2 Earnings: What Key Metrics Have to Say
NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates
NVCR: What are Zacks experts saying now?
Zacks Private Portfolio Services
NovoCure (NVCR) Soars 5.3%: Is Further Upside Left in the Stock?
What Makes NovoCure (NVCR) a New Buy Stock
NVCR Stock Dips Despite Positive OS Data From Phase 3 PANOVA-3 Trial
Other News for NVCR
NovoCure: Cash Burn, A Costly Launch, And A Maturing Business Signal More Pain Ahead
Insider Buying: Christoph Brackmann Acquires 20,000 Shares of NovoCure Ltd (NVCR)
NovoCure's Wearable Oncology Edge And Compelling Valuation
Top 3 Health Care Stocks That May Explode In July
Wells Fargo Downgrades NovoCure (NVCR) with Significant Price Target Cut | NVCR Stock News